These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17145809)

  • 41. Expression and mutational status of PDGFR in thymic tumours.
    Meister M; Kahl P; Muley T; Morresi-Hauf A; Sebening C; Kern MA; Breinig M; Schnabel P; Dienemann H; Schirmacher P; Rieker RJ
    Anticancer Res; 2009 Oct; 29(10):4057-61. PubMed ID: 19846951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
    Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
    Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
    Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
    Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series.
    Gomes AL; Gouveia A; Capelinha AF; de la Cruz D; Silva P; Reis RM; Pimenta A; Lopes JM
    J Clin Pathol; 2008 Feb; 61(2):203-8. PubMed ID: 17827398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.
    Tamborini E; Papini D; Mezzelani A; Riva C; Azzarelli A; Sozzi G; Pierotti MA; Pilotti S
    Br J Cancer; 2001 Aug; 85(3):405-11. PubMed ID: 11487273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection.
    Soroceanu L; Akhavan A; Cobbs CS
    Nature; 2008 Sep; 455(7211):391-5. PubMed ID: 18701889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression and molecular analysis of c-kit and PDGFRs in Kaposi's sarcoma of different stages and epidemiological settings.
    Rossi G; Sartori G; Rusev BC; Sgambato A
    Histopathology; 2009 Apr; 54(5):619-22. PubMed ID: 19302534
    [No Abstract]   [Full Text] [Related]  

  • 48. PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor.
    Perrone F; Da Riva L; Orsenigo M; Losa M; Jocollè G; Millefanti C; Pastore E; Gronchi A; Pierotti MA; Pilotti S
    Neuro Oncol; 2009 Dec; 11(6):725-36. PubMed ID: 19246520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of imatinib mesylate in adjuvant therapy of extra-abdominal desmoid tumors.
    Ioannou M; Demertzis N; Iakovidou I; Kottakis S
    Anticancer Res; 2007; 27(2):1143-7. PubMed ID: 17465254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.
    Uccini S; Mannarino O; McDowell HP; Pauser U; Vitali R; Natali PG; Altavista P; Andreano T; Coco S; Boldrini R; Bosco S; Clerico A; Cozzi D; Donfrancesco A; Inserra A; Kokai G; Losty PD; Nicotra MR; Raschellà G; Tonini GP; Dominici C
    Clin Cancer Res; 2005 Jan; 11(1):380-9. PubMed ID: 15671569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).
    Heinrich MC; McArthur GA; Demetri GD; Joensuu H; Bono P; Herrmann R; Hirte H; Cresta S; Koslin DB; Corless CL; Dirnhofer S; van Oosterom AT; Nikolova Z; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2006 Mar; 24(7):1195-203. PubMed ID: 16505440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imatinib mesylate in chordoma.
    Casali PG; Messina A; Stacchiotti S; Tamborini E; Crippa F; Gronchi A; Orlandi R; Ripamonti C; Spreafico C; Bertieri R; Bertulli R; Colecchia M; Fumagalli E; Greco A; Grosso F; Olmi P; Pierotti MA; Pilotti S
    Cancer; 2004 Nov; 101(9):2086-97. PubMed ID: 15372471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.
    Heinrich MC; Joensuu H; Demetri GD; Corless CL; Apperley J; Fletcher JA; Soulieres D; Dirnhofer S; Harlow A; Town A; McKinley A; Supple SG; Seymour J; Di Scala L; van Oosterom A; Herrmann R; Nikolova Z; McArthur AG;
    Clin Cancer Res; 2008 May; 14(9):2717-25. PubMed ID: 18451237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth factor receptor expression in orbital lymphangioma: possible therapeutic implications.
    Esmaeli B; Prieto VG; Gonnering R; Hawes MJ; Diba R; Saadati HG; Shepler TR; Karcioglu Z
    Orbit; 2004 Dec; 23(4):263-9. PubMed ID: 15590529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression and mutational analyses of KIT and PDGFR-alpha in sarcomatoid renal cell carcinoma.
    Petit A; Castillo M; Gaspa A; Colomer D; Garcia de Albéniz X; Moreno C; Camós M; Mellado B; Mallofré C
    Histopathology; 2009 Aug; 55(2):230-2. PubMed ID: 19694830
    [No Abstract]   [Full Text] [Related]  

  • 56. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
    Martinho O; Gonçalves A; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Reis RM; Longatto-Filho A
    Gynecol Oncol; 2008 Nov; 111(2):350-5. PubMed ID: 18708242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas.
    Tamborini E; Virdis E; Negri T; Orsenigo M; Brich S; Conca E; Gronchi A; Stacchiotti S; Manenti G; Casali PG; Pierotti MA; Pilotti S
    Neuro Oncol; 2010 Aug; 12(8):776-89. PubMed ID: 20164240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene.
    Schildhaus HU; Cavlar T; Binot E; Büttner R; Wardelmann E; Merkelbach-Bruse S
    J Pathol; 2008 Oct; 216(2):176-82. PubMed ID: 18686281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate).
    Mukherjee J; Kamnasaran D; Balasubramaniam A; Radovanovic I; Zadeh G; Kiehl TR; Guha A
    Cancer Res; 2009 Jun; 69(12):5099-107. PubMed ID: 19509233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines.
    Chen KT; Lin JD; Liou MJ; Weng HF; Chang CA; Chan EC
    Cancer Lett; 2006 Jan; 231(2):192-205. PubMed ID: 16126335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.